Schonfeld Strategic Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Sell |
|
|||||
|
2025
Q1 | $9.41M | Sell |
|
|||||
|
2024
Q4 | $19.1M | Sell |
|
|||||
|
2024
Q3 | $34.1M | Buy |
|
|||||
|
2024
Q2 | $13.4M | Sell |
|
|||||
|
2024
Q1 | $15.4M | Sell |
|
|||||
|
2023
Q4 | $15.7M | Buy |
|
|||||
|
2023
Q3 | $3.64M | Buy |
|
|||||
|
2023
Q2 | $2.78M | Buy |
|
|||||
|
2023
Q1 | $2.24M | Sell |
|
|||||
|
2022
Q4 | $8.29M | Buy |
|
|||||
|
2022
Q3 | $1.6M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.72M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.83M | Buy |
|
|||||
|
2021
Q1 | $1.04M | Sell |
|
|||||
|
2020
Q4 | $4.11M | Sell |
|
|||||
|
2020
Q3 | $4.31M | Buy |
|
|||||
|
2020
Q2 | $2.14M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.59M | Sell |
|
|||||
|
2019
Q3 | $3.83M | Sell |
|
|||||
|
2019
Q2 | $10.5M | Sell |
|
|||||
|
2019
Q1 | $21.7M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $997K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $354K | Buy |
|